⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 1, 2024Addiction Research & Theory

Impact of the COVID-19 pandemic on health care utilization for commercial and Medicaid beneficiaries with opioid use disorder

Lavonia Smith LeBeau Michael Head Rachel Mosher Henke Kenneth C. Pack Mackenzie C. White Norah Mulvaney Day Teresa B. Gibson Michael Davenport Daniel Chen Michael D. Stein Frank Meng Justeen Hyde Nicholas A. Livingston

View Full Paper

Ask AI

Bookmark

Share

Abstract

Introduction We sought to examine how COVID-19 affected opioid use disorder (OUD)-specific health care utilization for insured individuals with preexisting OUD during the first year of the pandemic.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

LeBeau et al. (2024) studied this question.

synapsesocial.com/papers/68e6219fb6db6435875b3c23 https://doi.org/10.1080/16066359.2024.2373138

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Telehealth Utilization for Opioid Use Disorder: A Nationwide Analysis Before and After the COVID-19 Public Health Emergency Declaration2024 · 1 citations
2Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members2024
3The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment2024 · 4 citations
4Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 PandemicCohort Study · 2022 · 145 citations
5Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid ProgramsCross-Sectional Study · 2023 · 21 citations